iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCPK: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the second quarter ended June 30, 2023. The Company’s Quarterly Report on Form 10-Q, which includes its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2023 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, the Company’s SEDAR profile at www.sedar.com, and on the Company’s website at www.iAnthus.com. The Company’s financial statements are reported in accordance with U.S. generally accepted accounting principles (“GAAP”). All currency is expressed in U.S. dollars.Second Quarter 2023 Financial Highlights
- Revenue of $38.7 million, a sequential increase of 5.2% from Q1 2023 and a decrease of 11.0% from the same quarter in the prior year.
- Gross profit of $18.4 million, a sequential increase of 18.7% from Q1 2023 and a decrease of 6.5% from the same quarter in the prior year.
- Gross margin of 47.5%, reflecting a sequential increase of 529bps when compared to Q1 2023 and an increase of 227bps from the same quarter in the prior year.
- Net loss of $20.1 million, or a net loss of $0.00 per share, compared to a net loss of $18.6 million, or a net loss of $0.00 per share in Q1 2023, and compared to a net loss of $373.6 million, or a net loss of $0.65 per share, in the same quarter in the prior year.
- Adjusted EBITDA(6) of ($0.4) million, a sequential decrease from an Adjusted EBITDA of $0.9 million in Q1 2023, and down from $2.3 million from the same quarter in the prior year. EBITDA and Adjusted EBITDA are non-GAAP measures. Reconciliation tables of EBITDA and Adjusted EBITDA as used in this press release to GAAP are included below.
| Table 1: Financial Results | ||||||
| in thousands of US$, except share and per share amounts (unaudited) | Q2 2023 | Q1 2023 | Q2 2022 | |||
| Revenue | $ | 38,715 | $ | 36,753 | $ | 43,481 |
| Gross profit | 18,390 | 15,512 | 19,668 | |||
| Gross margin | 47.5 % | 42.2 % | 45.2 % | |||
| Net loss | (20,149) | (18,595) | (373,562) | |||
| Net loss per share | (0.00) | (0.00) | (0.65) |
| Table 2: Reconciliation of Net Loss to EBITDA and Adjusted EBITDA | ||||||
| in thousands of US$ | Q2 2023 | Q1 2023 | Q2 2022 | |||
| Net loss | $ | (20,149) | $ | (18,595) | $ | (373,562) |
| Depreciation and amortization | 6,809 | 6,991 | 7,394 | |||
| Interest expense, net | 3,895 | 3,731 | 5,777 | |||
| Income tax expense | 5,442 | 3,799 | 5,391 | |||
| EBITDA (Non-GAAP) (6) | $ | (4,003) | $ | (4,074) | $ | (355,000) |
| Adjustments | ||||||
| Write-downs and other charges, net | 20 | 516 | 154 | |||
| Inventory reserves and write-downs | – | 356 | 177 | |||
| Accretion expense | 974 | 978 | 775 | |||
| Share-based compensation (1) | 1,593 | 1,489 | 21,372 | |||
| Losses from change in fair value of financial instruments | 11 | 33 | 138 | |||
| Debt obligation fees (2) | – | – | 390 | |||
| Non-recurring charges (3) | 1,092 | 529 | 18,218 | |||
| Loss on debt extinguishment (4) | – | 1,288 | 316,577 | |||
| Other income (5) | (117) | (220) | (527) | |||
| Total Adjustments | $ | 3,573 | $ | 4,969 | $ | 357,274 |
| Adjusted EBITDA (Non-GAAP) (6) | $ | (430) | $ | 895 | $ | 2,274 |
(1) Represents ordinary share-based compensation expense for Q2 2023 and Q1 2023. Q2 2022 reflects a $21.0 million share-based compensation expense related to the graded vesting from the restricted stock units granted as a result of closing the Company’s Recapitalization Transaction on June 24, 2022.
(2) Reflects accrued interest on the exit fee owed to the holders of the Company’s 13.0% senior secured convertible debentures. As the Company’s Recapitalization Transaction closed on June 24, 2022, the Company will no longer incur debt obligation fees relating to such debentures.
(3) Includes one-time, non-recurring costs related to the Company’s Recapitalization Transaction, its strategic review process, ongoing legal disputes, and severance and other non-recurring costs associated with having become a U.S. reporting company. These non-recurring costs are offset by insurance proceeds received as reimbursement for certain legal costs incurred.
(4) Q1 2023 reflects a one-time loss of $1.3 million on debt extinguishment related to the amendment of the $11.0 million senior secured bridge notes issued by iAnthus New Jersey, LLC. Q2 2022 reflects one-time loss of $316.6 million on debt extinguishment related to closing of the Company’s Recapitalization Transaction.
(5) Q2 2023 and Q1 2023 reflect approximately $0.1 million related to payroll tax refunds, and accounts payable write-offs of approximately $0.1 million. Q2 2022 reflects accounts payable write-offs of $0.3 million and payroll tax refunds of $0.2 million.
(6) See “Non-GAAP Financial Information” below for more information regarding the Company’s use of non-GAAP financial measures.Non-GAAP Financial Information
This press release includes certain non-GAAP financial measures as defined by the SEC and the Canadian Securities Administrators. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in the tables above. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.
In evaluating our business, we consider and use EBITDA as a supplemental measure of operating performance. We define EBITDA as earnings before interest, taxes, depreciation and amortization. We present EBITDA because we believe it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. We define Adjusted EBITDA as EBITDA before stock-based compensation, accretion expense, write-downs and impairments, gains and losses from changes in fair values of financial instruments, income or losses from equity-accounted investments, changes in accounting policy, non-recurring costs related to the Company’s Recapitalization Transaction, and litigation costs related to ongoing legal proceedings.
EBITDA and Adjusted EBITDA are not standardized financial measures defined under GAAP, and are not a measure of operating income, operating performance or liquidity presented in accordance with GAAP. EBITDA and Adjusted EBITDA have limitations as an analytical tool, and when assessing the Company’s operating performance, investors should not consider EBITDA or Adjusted EBITDA in isolation, or as a substitute for net income (loss) or other consolidated income statement data prepared in accordance with GAAP. Among other things, EBITDA and Adjusted EBITDA do not reflect the Company’s actual cash expenditures. Other companies may calculate similar measures differently than us, limiting their usefulness as comparative tools. We compensate for these limitations by relying on GAAP results and using EBITDA and Adjusted EBITDA only as supplemental information.
